Insider Trading Activity For Allergan plc (NYSE:AGN)
Matthew M. Walsh , CFO of Allergan plc (NYSE:AGN) reportedly Bought 1,000 shares of the company’s stock at an average price of 153.96 for a total transaction amount of $153,960.00 SEC Form
Insider Trading History For Allergan plc (NYSE:AGN)
Analyst Ratings History For Allergan plc (NYSE:AGN)
- On 4/5/2016 Nomura Reiterated Rating Buy with a price target of $350.00 to $330.00
- On 4/7/2016 Susquehanna Bancshares Downgraded rating Positive to Neutral with a price target of $345.00 to $275.00
- On 4/7/2016 Canaccord Genuity Reiterated Rating Buy
- On 4/7/2016 Raymond James Financial Lower Price Target of rating Outperform with a price target of $317.00 to $275.00
- On 4/12/2016 S&P Equity Research Reiterated Rating Buy
- On 4/18/2016 Guggenheim Initiated Coverage of rating Neutral
- On 11/21/2016 William Blair Reiterated Rating Market Perform
Dividend Information For Allergan plc (NYSE:AGN)
Allergan plc (NYSE:AGN) pays an annual dividend of $2.88 with a yield of 1.88% and an average dividend growth of 141.00% (3 Year Average).
Dividend History For Allergan plc (NYSE:AGN)
Recent Trading Activity for Allergan plc (NYSE:AGN)
Shares of Allergan plc closed the previous trading session at 153.46 up +0.24 0.16% with 153.9600067138672 shares trading hands.